Axalta Coating Systems (AXTA) downside risk is nearly priced in, underpinned by resilient performance of its core segments and strong execution from the management, UBS analysts said Monday in a research note.
Axalta Coating's stock is almost pricing in the analysts' downside scenario, which assumes sales declining about 9% below their estimate of 2025 sales growth of 1.1%. The analysts are also forecasting $930M in earnings before interest, taxes, depreciation and amortization, or EBITDA, about 18% below their 2025 EBITDA estimate of $1.14B. This leads to an average enterprise value/EBITDA multiple, of about $33 per share, which is 5% above current trading.
Looking ahead to 2025/26, the analysts assume only new wins and 2% declines in auto production versus flat previously. They also sees less downside potential in industrial and refinish volumes following a period of weakening already.
UBS upgraded Axalta Coating to buy from neutral, but decreased their price target on the stock to $40 from $42.
Price: 29.22, Change: -0.51, Percent Change: -1.72
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。